Eps8 Antibodies

Santa Cruz Biotechnology delivers a wide array of Eps8 monoclonal antibodies for investigating the role of epidermal growth factor receptor pathway substrate 8 (Eps8). The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Eps8 functions as a key regulator of actin dynamics and cell signaling pathways, influencing essential cellular processes such as migration, proliferation, and differentiation. Understanding Eps8 activity is crucial for normal cellular function and development. Research has shown that alterations in Eps8 expression contribute to various diseases, particularly cancer development and progression. Eps8 monoclonal antibodies enable precise detection and analysis of Eps8 expression patterns across different tissue types and experimental conditions. Researchers can utilize specific conjugates, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), for enhanced visualization and quantification. Current investigations continue to reveal new insights about Eps8's role in cellular regulation and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing Eps8 research and potential therapeutic developments.